The missing link: Family physician perspectives on barriers and enablers to prescribing a new Meningococcal B vaccine and other recommended, non-government funded vaccines

摘要: Abstract Objectives To determine factors influencing Family Physician (FP) uptake of non government-funded vaccines, and to explore FP attitudes towards the introduction use a new vaccine protect against serogroup B meningococcal disease inform its future into Australian Immunisation Schedule. Design setting participants Quantitative, self-administered state-wide questionnaire mailed all FPs in South Australia ( n  = 1786). Results from 523 respondents Australia, collected between June October 2013. Main outcome measures Self-reported immunisation counselling practices; knowledge, barriers prescribing Meningococcal (Men B) other recommended, non-funded immunisations. The response rate was 30%  = 523). While most (59%) had worked general practice for over 20 years, only 39% ever personal or professional experience with case invasive (IMD). Most (63%) were aware that being developed, 93% agreed this should be government-funded. ranked Men as highest priority receive funding eight currently strategies. High cost low patient socioeconomic status identified definite vaccines by 59% respondents. Past IMD significantly affected practices. Conclusions IMD, while encountered rarely clinical practice, is considered an important vaccinate FPs. Cost perceived patients are substantial inclusion such on National Program likely improve equity access.